122 related articles for article (PubMed ID: 7538095)
1. [Pharmacological modulation of the complement system: an opportunity for successful xenotransplantation].
Heckl-Ostreicher B; Kirschfink M
Immun Infekt; 1995 Apr; 23(2):53-4. PubMed ID: 7538095
[TBL] [Abstract][Full Text] [Related]
2. [Significance of the complement system for xenotransplantation: strategies for therapeutic intervention].
Kirschfink M; Haferkamp A; Pomer S; Chrupcala M; Wosnik A; Heckl-Ostreicher B
Zentralbl Chir; 1998; 123(7):793-7. PubMed ID: 9746977
[TBL] [Abstract][Full Text] [Related]
3. Porcine complement regulators protect aortic smooth muscle cells poorly against human complement-induced lysis and proliferation: consequences for xenotransplantation.
Capey S; van den Berg CW
Xenotransplantation; 2005 May; 12(3):217-26. PubMed ID: 15807772
[TBL] [Abstract][Full Text] [Related]
4. [Complement regulatory factors and immunologic recognition mechanism between species].
Seya T; Matsunoto M
Nihon Rinsho Meneki Gakkai Kaishi; 1995 Dec; 18(6):637-42. PubMed ID: 8963770
[No Abstract] [Full Text] [Related]
5. Tissue expression of human decay accelerating factor, a regulator of complement activation expressed in mice: a potential approach to inhibition of hyperacute xenograft rejection.
Cary N; Moody J; Yannoutsos N; Wallwork J; White D
Transplant Proc; 1993 Feb; 25(1 Pt 1):400-1. PubMed ID: 7679815
[No Abstract] [Full Text] [Related]
6. Phagocytosis of Mycobacterium leprae by human monocyte-derived macrophages is mediated by complement receptors CR1 (CD35), CR3 (CD11b/CD18), and CR4 (CD11c/CD18) and IFN-gamma activation inhibits complement receptor function and phagocytosis of this bacterium.
Schlesinger LS; Horwitz MA
J Immunol; 1991 Sep; 147(6):1983-94. PubMed ID: 1679838
[TBL] [Abstract][Full Text] [Related]
7. Ethical considerations in clinical cardiac xenografting.
Pierson RN; White DJ; Wallwork J
J Heart Lung Transplant; 1993; 12(5):876-8. PubMed ID: 7694655
[No Abstract] [Full Text] [Related]
8. Glomerulonephritis and complement regulatory proteins.
Nangaku M; Johnson RJ; Couser WG
Exp Nephrol; 1997; 5(5):345-54. PubMed ID: 9386969
[No Abstract] [Full Text] [Related]
9. Complement regulatory molecules: application to therapy and transplantation.
Morgan BP
Immunol Today; 1995 Jun; 16(6):257-9. PubMed ID: 7544975
[No Abstract] [Full Text] [Related]
10. The effect of soluble complement receptor type 1 on acute humoral xenograft rejection in hDAF-transgenic pig-to-primate life-supporting kidney xenografts.
Lam TT; Hausen B; Hook L; Lau M; Higgins J; Christians U; Jacobsen W; Baluom M; Duthaler R; Katopodis A; Chavez G; Cozzi E; Harrison R; Schuurman HJ; Borie D; Morris RE
Xenotransplantation; 2005 Jan; 12(1):20-9. PubMed ID: 15598270
[TBL] [Abstract][Full Text] [Related]
11. The regulation of the complement system: insights from genetically-engineered mice.
Turnberg D; Botto M
Mol Immunol; 2003 Sep; 40(2-4):145-53. PubMed ID: 12914820
[TBL] [Abstract][Full Text] [Related]
12. Possibility of prevention of hyperacute rejection by DAF and CD59 in xenotransplantation.
Miyagawa S; Shirakura R; Matsumiya G; Nakata S; Matsuda H; Hatanaka M; Matsumoto M; Seya T
Transplant Proc; 1994 Jun; 26(3):1235-8. PubMed ID: 7518114
[No Abstract] [Full Text] [Related]
13. [Cell-associated complement regulatory proteins and their relation to disease processes].
Seya T
Rinsho Byori; 1991 Dec; 39(12):1317-24. PubMed ID: 1723433
[TBL] [Abstract][Full Text] [Related]
14. Targeting complement in therapy.
Kirschfink M
Immunol Rev; 2001 Apr; 180():177-89. PubMed ID: 11414360
[TBL] [Abstract][Full Text] [Related]
15. Xenotransplantation: how to overcome the complement obstacle?
Mollnes TE; Fiane AE
Mol Immunol; 1999; 36(4-5):269-76. PubMed ID: 10403480
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic inhibition of the complement system.
Makrides SC
Pharmacol Rev; 1998 Mar; 50(1):59-87. PubMed ID: 9549758
[TBL] [Abstract][Full Text] [Related]
17. Mice transgenic for human CD46 and CD55 are protected from human complement attack.
Mulder LC; Mora M; Ciccopiedi E; Melli C; Nuti S; Marinucci G; Bruzzone P; Lazzeri M; Lorenzini R; Alfani D
Transplant Proc; 1995 Feb; 27(1):333-5. PubMed ID: 7533403
[No Abstract] [Full Text] [Related]
18. Reaction of complement with endothelial cells in a model of xenotransplantation.
Dalmasso AP; Platt JL; Bach FH
Clin Exp Immunol; 1991 Oct; 86 Suppl 1(Suppl 1):31-5. PubMed ID: 1718641
[TBL] [Abstract][Full Text] [Related]
19. The possible role of membrane complement regulators in vasculitis.
Daha MR
Behring Inst Mitt; 1993 Aug; (92):184-90. PubMed ID: 7504449
[TBL] [Abstract][Full Text] [Related]
20. Protection of mammalian cells from complement-mediated lysis by transfection of human membrane cofactor protein and decay-accelerating factor.
Oglesby TJ; White D; Tedja I; Liszewski K; Wright L; Van den Bogarde J; Atkinson JP
Trans Assoc Am Physicians; 1991; 104():164-72. PubMed ID: 1726964
[No Abstract] [Full Text] [Related]
[Next] [New Search]
